Friday Health Roundup: AI, Cancer Drugs, and Transparency

Kilder

• STAT: Nonprofit buys experimental cancer drug to maintain patient access
• STAT: Abridge inks deals with Nvidia and Lilly - statnews.com
• STAT: Study highlights influence of socioeconomic status on children’s brain development - statnews.com
• STAT: STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
• STAT: RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year - statnews.com
• STAT: STAT+: AMA and lawmakers push back on AI care denials
• STAT: STAT+: ‘Synthetic lethality’ could trigger another round of biotech M&A
• Raps: Recon: MHRA approves Novo’s weight-loss pill; Some US employers look to cut GLP-1 coverage in 2027 - RAPS.org
• STAT: Opinion: We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.